Ardent Health (ARDT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $11.95, -2.05% vs the prior close of $12.20.
- Volume 660.13K shares, 1.5x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ARDT dips 2.0% to $11.95. Closed at $11.95, -2.05% vs the prior close of $12.20. Day range $11.95–$12.47, opened at $12.33.
ARDT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ARDT dips 2.0% to $11.95
- Closed at $11.95, -2.05% vs the prior close of $12.20. Day range $11.95–$12.47, opened at $12.33.
- Volume was 660.13K shares, 1.5x its 50-day average of 428.89K.
- Price is +9.2% vs its 50-day average ($10.94) and +21.6% vs its 200-day average ($9.83).
- 52-week range $7.71–$15.48; today's close sits at 55% of that range, 22.8% below the 52-week high.
Oct 15, 2026 — ARDT rises 2.1% to $12.20, a 6-month high, 10 up days in a row
- Closed at $12.20, +2.09% vs the prior close of $11.95. Day range $11.70–$12.23, opened at $11.99.
- Volume was 537.60K shares, 1.2x its 50-day average of 438.46K.
- Price is +11.6% vs its 50-day average ($10.93) and +24.4% vs its 200-day average ($9.81).
- 52-week range $7.71–$15.48; today's close sits at 58% of that range, 21.2% below the 52-week high.
- That makes 10 straight gains.
Oct 14, 2026 — ARDT rises 2.2% to $11.95, a 6-month high on 2.5x normal volume
- Closed at $11.95, +2.22% vs the prior close of $11.69. Day range $11.55–$12.00, opened at $11.72.
- Volume was 1.04M shares, 2.5x its 50-day average of 425.85K — unusually heavy trading.
- Price is +9.5% vs its 50-day average ($10.91) and +22.0% vs its 200-day average ($9.79).
- 52-week range $7.71–$15.48; today's close sits at 55% of that range, 22.8% below the 52-week high.
- That makes 9 straight gains.
Oct 13, 2026 — ARDT rises 1.4% to $11.69, a 6-month high, 8 up days in a row
- Closed at $11.69, +1.39% vs the prior close of $11.53. Day range $11.03–$11.81, opened at $11.58.
- Volume was 630.40K shares, 1.5x its 50-day average of 421.49K.
- Price is +7.4% vs its 50-day average ($10.89) and +19.5% vs its 200-day average ($9.78).
- 52-week range $7.71–$15.48; today's close sits at 51% of that range, 24.5% below the 52-week high.
- That makes 8 straight gains.
Oct 12, 2026 — ARDT rises 2.0% to $11.53, a 1-month high, 7 up days in a row
- Closed at $11.53, +2.04% vs the prior close of $11.30. Day range $11.03–$11.63, opened at $11.36.
- Volume was 574.20K shares, 1.4x its 50-day average of 418.49K.
- Price is +6.1% vs its 50-day average ($10.87) and +18.0% vs its 200-day average ($9.77).
- 52-week range $7.71–$15.48; today's close sits at 49% of that range, 25.5% below the 52-week high.
- That makes 7 straight gains.
Oct 9, 2026 — ARDT rises 2.1% to $11.30, a 1-month high, 6 up days in a row
- Closed at $11.30, +2.08% vs the prior close of $11.07. Day range $10.90–$11.44, opened at $11.08.
- Volume was 568.30K shares, 1.4x its 50-day average of 416.18K.
- Price is +4.1% vs its 50-day average ($10.85) and +15.9% vs its 200-day average ($9.75).
- 52-week range $7.71–$15.48; today's close sits at 46% of that range, 27.0% below the 52-week high.
- That makes 6 straight gains.
Oct 8, 2026 — ARDT rises 1.7% to $11.07, 5 up days in a row
- Closed at $11.07, +1.75% vs the prior close of $10.88. Day range $10.71–$11.13, opened at $10.92.
- Volume was 721.80K shares, 1.7x its 50-day average of 417.04K.
- Price is +2.1% vs its 50-day average ($10.84) and +13.6% vs its 200-day average ($9.74).
- 52-week range $7.71–$15.48; today's close sits at 43% of that range, 28.5% below the 52-week high.
- That makes 5 straight gains.
Oct 7, 2026 — ARDT rises 1.9% to $10.88, 4 up days in a row
- Closed at $10.88, +1.87% vs the prior close of $10.68. Day range $10.55–$10.95, opened at $10.55.
- Volume was 684.10K shares, 1.6x its 50-day average of 415.52K.
- Price is +0.4% vs its 50-day average ($10.84) and +11.8% vs its 200-day average ($9.73).
- 52-week range $7.71–$15.48; today's close sits at 41% of that range, 29.7% below the 52-week high.
- That makes 4 straight gains.
Oct 6, 2026 — ARDT rises 1.2% to $10.68, 3 up days in a row
- Closed at $10.68, +1.23% vs the prior close of $10.55. Day range $10.49–$10.84, opened at $10.63.
- Volume was 290.30K shares, 0.7x its 50-day average of 422.69K.
- Price is -1.6% vs its 50-day average ($10.85) and +9.9% vs its 200-day average ($9.72).
- 52-week range $7.71–$15.48; today's close sits at 38% of that range, 31.0% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — ARDT rises 2.0% to $10.55
- Closed at $10.55, +2.03% vs the prior close of $10.34. Day range $10.34–$10.73, opened at $10.34.
- Volume was 376.70K shares, 0.9x its 50-day average of 434.30K.
- Price is -2.8% vs its 50-day average ($10.85) and +8.6% vs its 200-day average ($9.71).
- 52-week range $7.71–$15.48; today's close sits at 37% of that range, 31.8% below the 52-week high.
Oct 2, 2026 — ARDT rises 0.9% to $10.34
- Closed at $10.34, +0.88% vs the prior close of $10.25. Day range $10.26–$10.56, opened at $10.29.
- Volume was 280.60K shares, 0.6x its 50-day average of 436.54K.
- Price is -4.8% vs its 50-day average ($10.86) and +6.6% vs its 200-day average ($9.70).
- 52-week range $7.71–$15.48; today's close sits at 34% of that range, 33.2% below the 52-week high.
ARDT latest news & SEC filings
Every SEC filing by or about ARDT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lumsdaine Alfred had withheld for taxes 3,389 shares at $10.54 (≈$35.72K) on Sep 25, 2026; now holds 325,794
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Petrovich Stephen C. had withheld for taxes 788 shares at $10.54 (≈$8.31K) on Sep 25, 2026; now holds 773,919
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Byers David Raynor had withheld for taxes 524 shares at $10.54 (≈$5.52K) on Sep 25, 2026; now holds 129,921
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 27, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 25, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 20, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.62B (prior year $1.65B) (-1.4% vs Jun 30, 2025)
- Net income: $16.90M (prior year $72.95M) (-76.8% vs Jun 30, 2025)
- Diluted EPS: $0.12 (prior year $0.52) (-76.9% vs Jun 30, 2025)
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade ARDT
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Mar 4, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.69% (largest 3.2%).
- Liquidity: about 499.00K shares (≈$5.96M) trade per day on average.
- 52-week position: $11.95 vs a range of $7.71–$15.48 (55% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 0 sales; latest: Alfred Lumsdaine bought 10,000 shares on Jun 5, 2026.
- Latest filings: 8-K Sep 4, 2026; 10-Q Aug 10, 2026; 8-K Aug 4, 2026.
- Share count: 141.05M shares outstanding (Aug 7, 2026), -1.4% vs a year earlier.
- Listing: NYSE · industry: Services-General Medical & Surgical Hospitals, NEC.
ARDT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 12.33 | 12.47 | 11.95 | 11.95 | 660.13K |
| Oct 15, 2026 | 11.99 | 12.23 | 11.70 | 12.20 | 537.60K |
| Oct 14, 2026 | 11.72 | 12.00 | 11.55 | 11.95 | 1.04M |
| Oct 13, 2026 | 11.58 | 11.81 | 11.03 | 11.69 | 630.40K |
| Oct 12, 2026 | 11.36 | 11.63 | 11.03 | 11.53 | 574.20K |
| Oct 9, 2026 | 11.08 | 11.44 | 10.90 | 11.30 | 568.30K |
| Oct 8, 2026 | 10.92 | 11.13 | 10.71 | 11.07 | 721.80K |
| Oct 7, 2026 | 10.55 | 10.95 | 10.55 | 10.88 | 684.10K |
| Oct 6, 2026 | 10.63 | 10.84 | 10.49 | 10.68 | 290.30K |
| Oct 5, 2026 | 10.34 | 10.73 | 10.34 | 10.55 | 376.70K |
| Oct 2, 2026 | 10.29 | 10.56 | 10.26 | 10.34 | 280.60K |
| Oct 1, 2026 | 10.22 | 10.40 | 10.08 | 10.25 | 333.10K |
| Sep 30, 2026 | 10.62 | 10.62 | 10.31 | 10.34 | 363.30K |
| Sep 29, 2026 | 10.44 | 10.63 | 10.29 | 10.58 | 396.30K |
| Sep 28, 2026 | 10.50 | 10.74 | 10.32 | 10.47 | 408.70K |
| Sep 25, 2026 | 10.45 | 10.69 | 10.36 | 10.54 | 251.90K |
| Sep 24, 2026 | 10.65 | 10.81 | 10.44 | 10.48 | 470.70K |
| Sep 23, 2026 | 10.71 | 11.03 | 10.47 | 10.64 | 427.20K |
| Sep 22, 2026 | 10.70 | 11.03 | 10.68 | 10.95 | 504.20K |
| Sep 21, 2026 | 10.51 | 10.61 | 10.36 | 10.61 | 456.80K |
About Ardent Health
Ardent Health (ARDT) is listed on the NYSE and classified by the SEC under “Services-General Medical & Surgical Hospitals, NEC”. Its business address is in BRENTWOOD, TN. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1756655.
ARDT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Peter C B Bynoe | Director | Apr 2, 2026 |
| Martin Bonick | President and CEO | Apr 2, 2026 |
| Peter J. Bulgarelli | Director | Apr 2, 2026 |
| Suzanne Campion | Director | Apr 2, 2026 |
| Dave Caspers | CEO and President | Jul 2, 2026 |
| Robert Demichiei | Director | Jun 8, 2026 |
| William M Goodyear | Director | Apr 2, 2026 |
| Ellen Havdala | Director | Apr 2, 2026 |
| Edmondo Robinson | Director | Apr 2, 2026 |
| Rahul Sen | Director | Apr 2, 2026 |
| Mark R Sotir | Chair of the Board | Apr 2, 2026 |
| Robert Thomas Webb | Director | Apr 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Martin Bonick | President and CEO | Apr 2, 2026 |
| David Raynor Byers | SVP & Chief Accounting Officer | Sep 29, 2026 |
| Dave Caspers | CEO and President | Jul 2, 2026 |
| Ethan Chernin | President of Health Services | Mar 13, 2026 |
| Alfred Lumsdaine | Chief Financial Officer | Sep 29, 2026 |
| Stephen C. Petrovich | EVP, GC and Secretary | Sep 29, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 5, 2026 | Alfred Lumsdaine | Buy | 10,000 | $8.81 |
| Jun 5, 2026 | Alfred Lumsdaine | Buy | 10,000 | $8.81 |
| Jun 5, 2026 | Alfred Lumsdaine | Buy | 10,000 | $8.81 |
| Jun 5, 2026 | Alfred Lumsdaine | Buy | 10,000 | $8.81 |
| Jun 5, 2026 | Robert Demichiei | Buy | 11,260 | $8.73 |
| Jun 5, 2026 | Robert Demichiei | Buy | 11,260 | $8.73 |
| Jun 5, 2026 | Robert Demichiei | Buy | 11,260 | $8.73 |
| Jun 5, 2026 | Robert Demichiei | Buy | 11,260 | $8.73 |
ARDT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $6.32B | $135.81M | 0.96 | $470.51M |
| Dec 31, 2024 | $5.97B | $210.34M | 1.58 | $315.03M |
| Dec 31, 2023 | $5.41B | $53.90M | 0.43 | $221.70M |
| Dec 31, 2022 | $5.13B | $188.91M | 1.50 | $-38.36M |
Latest balance sheet: total assets $5.28B, total liabilities $3.54B, cash $724.48M (as of Jun 30, 2026).
ARDT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $10.75 |
| May 5, 2026 | 8-K Item 2.02 (results) | $10.13 |
| Mar 4, 2026 | 8-K Item 2.02 (results) | $9.64 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $14.05 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $10.65 |
| May 6, 2025 | 8-K Item 2.02 (results) | $13.01 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $14.01 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $16.05 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $16.27 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-General Medical & Surgical Hospitals, NEC
HCA Healthcare (HCA)Tenet Healthcare (THC)Universal Health Services (UHS)Surgery Partners (SGRY)Community Health Systems (CYH)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ARDT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.